Medpace Holdings (NASDAQ: MEDP) has announced that it will be releasing its financial results for the third quarter of 2024 on Monday 21st October 2024. The report will be made available after market close, allowing investors and analysts to evaluate the company's performance during this period.
Wall Street financial analysts are foreseeing that the establishment is likely to announce an estimated per share $2.78 profit for the quarter. Furthermore, it is anticipated that the company will disclose a total revenue of $540.99 million during the quarter.
The company's full-year performance has been analyzed by wall street analysts, who have shared their projections. According to the analysis, it is expected that the company will generate a total revenue of $2.14 billion. Additionally, the earnings per share for the company are also anticipated to reach profit of $11.56 over the course of the fiscal year.
During the same quarter of the previous year, the company's earnings report indicated a per-share income of $2.22. This noteworthy figure was a direct outcome of the company's total revenue, which reached an impressive $492.5 million during that specific period.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $2.75 | +42.5% | 528.10 M | +14.6% |
| Q1 2024 | $3.20 | +41.0% | 511.04 M | +17.7% |
| Q4 2023 | $2.46 | +16.0% | 498.40 M | +26.5% |
| Q3 2023 | $2.22 | +8.3% | 492.50 M | +28.3% |
| Q2 2023 | $1.93 | +32.2% | 460.87 M | +31.2% |
| *Growth on year-over-year basis | ||||
In addition, The firm will review the third quarter financial results on 22nd October 2024 at 09:00 AM eastern time, in a conference call with public.
Medpace Holdings (MEDP) experienced a trading range of $341.67 to $350.11, along with a total volume of 277.20 thousand shares during the day. The stock concluded Thursday's regular trading session at $342.89, demonstrating downfall of 1.04 percent.
